Atlas Trials

In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control

Clinical trial NCT03441568 · COMPLETED

Trial details

NCT number
NCT03441568
Sponsor
Bayer
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2018-09-26
Primary completion
2019-08-02
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.